Cytodyn Inc
Change company Symbol lookup
Select an option...
CYDY Cytodyn Inc
PRT PermRock Royalty Trust
PB Prosperity Bancshares Inc
MODV ModivCare Inc
ETNB 89Bio Inc
ETN Eaton Corporation PLC
AUD Audacy Inc
ETH Ethan Allen Interiors Inc
ETAC E.Merge Technology Acquisition Corp
ET Energy Transfer LP
Go

Health Care : Biotechnology |
Company profile

CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the clinical development and commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The Company's lead product candidate, PRO 140, belongs to a class of HIV therapies known as entry inhibitors that block HIV from entering into and infecting certain cells. The Company's product pipeline also includes Cytolin and CytoFeline. Cytolin is a mouse monoclonal antibody developed to identify a specific type of immune cell called a cytotoxic T cell, or cytotoxic T lymphocyte (CTL). CytoFeline is an anti-lymphocyte function-associated antigen-1 (LFA-1) antibody for the treatment of Feline Immunodeficiency Virus (FIV) infection. PRO 140 blocks HIV from entering a cell by binding to a molecule called C-C chemokine receptor type 5 (CCR5). The Company has finished Phase II clinical trials for PRO 140 with demonstrated antiviral activity in man.

Closing Price
$1.67
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
2,222,798
0
  • Prev Close
    1.67
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    2.2M
  • Last (time)
    3:59p ET 06/23/21
  • Last (size)
    215.0K
  • 52-Wk Range
    1.63 - 10.01
    LowHigh
  • (06/30/20 - 06/23/21)
    2.45%
  • 144.8%
  • Market Cap
    1.0B
  • Shares Outstanding
    612.9M
  • -0.31
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • -0.5
  • 0.13
  • --

Latest News

June 22, 2021
7:15 am ET
Accesswire
June 21, 2021
8:30 am ET
Globe Newswire
June 16, 2021
4:01 pm ET
Globe Newswire
June 10, 2021
9:30 am ET
PR Newswire
June 07, 2021
8:51 am ET
Globe Newswire
June 01, 2021
9:23 am ET
Globe Newswire
9:19 am ET
Globe Newswire
May 27, 2021
6:00 am ET
Globe Newswire
May 20, 2021
4:55 pm ET
Globe Newswire
May 18, 2021
10:30 am ET
MarketWatch
6:19 am ET
Globe Newswire
May 17, 2021
7:44 pm ET
Globe Newswire
10:27 am ET
Newsfile
9:11 am ET
Newsfile
12:16 am ET
PR Newswire
May 16, 2021
5:15 pm ET
Globe Newswire
3:30 pm ET
Newsfile
May 15, 2021
10:20 pm ET
Newsfile
2:13 pm ET
Newsfile
May 14, 2021
10:30 pm ET
Globe Newswire
7:43 pm ET
Newsfile
6:06 pm ET
BusinessWire
4:51 pm ET
Newsfile
2:36 pm ET
Newsfile
12:42 pm ET
Newsfile
11:11 am ET
Globe Newswire
11:05 am ET
Newsfile
11:00 am ET
BusinessWire
6:10 am ET
Accesswire
May 13, 2021
10:37 pm ET
Newsfile
10:00 pm ET
BusinessWire
7:20 pm ET
Newsfile
5:52 pm ET
PR Newswire
4:31 pm ET
Newsfile
1:45 pm ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.